ZITANEO-D-MET 500

Ensure Tight Control over this Menace with…

 

COMPOSITION

Dapagliflozin 10 mg + Sitagliptin 100 mg + Metformin Hcl 500 mg (In Extended Release form

INDICATION

  • Type 2 Diabetes
  • Insulin Resistance
  • Pre – Gestational

ZITANEO-D-MET 500

DAPAGLIFLOZIN

  • A highly potent, reversible & selective sodium glucose cotransporter-2 inhibitor
  • Early administered, selective inhibitor of dipeptidyl peptidase-4
  • Offers protective effect on the pancreatic beta cells thus limiting the progression of disease.’
  • Promotes glucose filtration through the kidney and into the urine to be eliminated from the body
  • Facilitates weight loss, BP reduction, protects kidney

     SITAGLIPTIN

  • Early administered, selective inhibitor of dipeptidyl peptidase-4
    Offers a protective effect on the pancreatic beta cells thus limiting
  • The progression of the disease.’
  • Safe with less incidence of hypoglycemia

   METFORMIN

  • Provides additive glycemic improvement
  • Controls body weight & body mass index